Potential Drug-Drug Interaction (DDI) occurring while treating complex or co-existing diseases with drug combinations may cause changes in drugs’ pharmacological activity. Therefore, DDI prediction has been an important task in the medical healthy machine learning community. Recently, graph-based learning methods have aroused widespread interest and is proved to be a priority for this task. However, these methods are often limited to exploiting the inter-view drug molecular structure and ignoring the drug’s intra-view interaction relationship, vital to capturing the complex DDI patterns. This study presents a new method, multi-view graph contrastive representation learning for drug-drug interaction prediction, MIRACLE for brevity, to capture inter-view molecule structure and intra-view interactions between molecules simultaneously. MIRACLE treats a DDI network as a multi-view graph where each node in the interaction graph itself is a drug molecular graph instance. We use GCN to encode DDI relationships and a bond-aware attentive message propagating method to capture drug molecular structure information in the MIRACLE learning stage. Also, we propose a novel unsupervised contrastive learning component to balance and integrate the multi-view information. Comprehensive experiments on multiple real datasets show that MIRACLE outperforms the state-of-the-art DDI prediction models consistently.

The Web Conference is announcing latest news and developments biweekly or on a monthly basis. We respect The General Data Protection Regulation 2016/679.